{
    "root": "35980489-2890-7cf8-e063-6294a90aa6ab",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250520",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ],
    "indications": {
        "text": "gabapentin indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gabapentin capsules tablets , usp supplied follows : 100 mg capsules : white off-white powder filled size \u201c 3 \u201d hard gelatin capsules opaque white colored cap opaque white colored body imprinted sg cap 179 body black ink , available : bottles 30 ndc 68071-2600-3 bottles 60 ndc 68071-2600-6 store gabapentin capsules tablets 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin is indicated for: \n                  \n                     Management of postherpetic neuralgia in adults\n       \n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "Postherpetic Neuralgia ( 2.1 ) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "Gabapentin capsules and tablets, USP are supplied as follows:\n                  100 mg capsules:\n                  White to off-white powder filled in size \u201c3\u201d hard gelatin capsules with opaque white colored cap and opaque white colored body imprinted \n  SG on cap and \n  179 on body with black ink, available in:\n \n                  BOTTLES OF 30 NDC 68071-2600-3\n                  BOTTLES OF 60 NDC 68071-2600-6\n                  Store gabapentin capsules and tablets at 25\u00b0C (77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "Gabapentin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}